Corient Private Wealth
TMO icon

Corient Private Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Corient Private Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$417M Sell
832,069
-731,634
-47% -$397M 0.6% 28
2025
Q4 		$866M Buy
1,563,703
+831,506
+114% +$470M 0.58% 25
2025
Q3 		$355M Sell
732,197
-143,246
-16% -$66.7M 0.56% 27
2025
Q2 		$355M Sell
875,443
-51,515
-6% -$21.5M 0.47% 33
2025
Q1 		$461M Buy
926,958
+31,031
+3% +$16.8M 0.75% 22
2024
Q4 		$465M Sell
895,927
-54,001
-6% -$29.7M 0.77% 19
2024
Q3 		$588M Buy
949,928
+23,467
+3% +$13.9M 0.92% 19
2024
Q2 		$512M Sell
926,461
-13,331
-1% -$7.64M 0.89% 18
2024
Q1 		$546M Sell
939,792
-3,762
-0.4% -$2.11M 0.97% 13
2023
Q4 		$501M Buy
943,554
+124,673
+15% +$60.3M 0.92% 16
2023
Q3 		$414M Sell
818,881
-9,704
-1% -$5.17M 0.95% 17
2023
Q2 		$432M Buy
828,585
+20,751
+3% +$11.2M 1% 15
2023
Q1 		$466M Buy
807,834
+195,489
+32% +$110M 1.25% 6
2022
Q4 		$337M Buy
+612,345
New +$324M 1.22% 8

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Corient Private Wealth's TMO Position: Q1 2026 in Review

Corient Private Wealth reduced its Thermo Fisher Scientific (TMO) stake by 47% in Q1 2026, selling an estimated $397M and leaving 832,069 shares worth $417M. The position accounts for 0.6% of the portfolio, ranked #28.

Corient Private Wealth first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $866M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Corient Private Wealth held 832,069 shares of Thermo Fisher Scientific worth $417M as of Q1 2026.
  • Corient Private Wealth sold 731,634 Thermo Fisher Scientific shares in Q1 2026, an estimated $397M.
  • Thermo Fisher Scientific made up 0.6% of Corient Private Wealth's portfolio in Q1 2026, its #28 holding.
  • Corient Private Wealth first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Thermo Fisher Scientific position peaked at $866M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.